PROGRAM AGENDA
12:00 - 12:40 PM
NETWORKING LUNCH
12:40 - 12:50 PM
Welcome & Opening Remarks
Presented By:
Stuart Abelson, President, Chairman & CEO - Ora
12:50 - 1:25 PM
Modern Life in the Digital Renaissance
Presented By:
Armida Ascano, Chief Content Officer - Trend Hunter
1:25 - 1:50 PM
The Already Here Pandemic of Dry Eye
Keynote Presenter:
James S Wolffsohn, BSc, MBA, PhD, FAAO, Professor of Optometry - Aston University
1:50 - 2:25 PM
Today's Therapies are Not Sufficient - a Marketplace Ripe for Innovation
Panelists:
Laura Downie, OD, PhD, Professor - University of Melbourne
David G Evans, OD, Clinical Research Investigator, Optometric Physician - Total Eye Care P.A Memphis
Victor Perez, MD, Professor of Ophthalmology, University of Miami Miller School of Medicine/ Director, Cornea Research Program - Bascom Palmer Eye Institute
Clark L. Springs, MD - Wilmington Eye
James S Wolffsohn, BSc, MBA, PhD, FAAO, Professor of Optometry - Aston University
Moderated By:
Laura Periman, MD, Founder and Director of Dry Eye Services and Clinical Research - Periman Eye Institute
2:25 - 2:55 PM
NETWORKING BREAK
2:55 - 3:55 PM
Potential untapped MOAs & Novel Therapies
Stuart Therapeutics | Eric Schlumpf, President & CEO
Azura Ophthalmics Limited | Charles Bosworth, PhD, Chief Medical Officer
Okyo Pharma Limited | Gary S. Jacob, PhD, CEO & Director
Tear Solutions | Anil C. Asrani, President & CEO
Oculis | Riad Sherif, MD, CEO
Aramis Biosciences | David S. Tierney, MD, CEO
Glia | Wei-Wei Change, PhD, President & Co-Founder
Moderated By:
George Ousler, Senior Vice President, Anterior Segment - Ora
3:55 - 4:55 PM
Optimizing Speed to Market - Clinical Pathway Acceleration
Presenters:
Marc Gleeson, CEO - Azura Ophthalmics Limited
George Ousler, Senior Vice President, Anterior Segment - Ora
David G Evans, OD, Clinical Research Investigator, Optometric Physician - Total Eye Care P.A Memphis
Gustavo de Moraes, MD, PhD, MPH, Chief Medical Officer - Ora / Associate Professor of Clinical Ophthalmology - Columbia University Irving Medical Center
Victor Perez, MD, Professor of Ophthalmology, University of Miami Miller School of Medicine/ Director, Cornea Research Program - Bascom Palmer Eye Institute
Laura Downie, OD, PhD - University of Melbourne
Sonja Krösser, PhD, VP Medical Science & Regulatory Affairs - Novaliq
Gustavo de Moraes, MD, PhD, MPH, Chief Medical Officer - Ora / Associate Professor of Clinical Ophthalmology - Columbia University Irving Medical Center
4:55 - 5:25 PM
The Value for Investment in New Therapies
Panelists:
Todd Brady, MD, PhD, President & CEO - Aldeyra
Doug Faunce, PhD, Executive Director, Head of Search and Evaluation for Eye Care - AbbVie Ventures
Céline Olmiere, PhD, Head - Théa Open Innovation
Mike Rosco, MD, Regional Medical Director - Harrow
Moderated By:
Stewart Sylvester, Chief Sales Officer - Ora
5:25 - 5:45 PM
Closing Remarks
5:45 - 6:45 PM
NETWORKING RECEPTION
PROGRAM AGENDA
12:00 - 12:40 PM
NETWORKING LUNCH
12:40 - 12:50 PM
Welcome & Opening Remarks
Presented By:
Stuart Abelson, President, Chairman & CEO - Ora
12:50 - 1:25 PM
Modern Life in the Digital Renaissance
Presented By:
Armida Ascano, Chief Content Officer - Trend Hunter
1:25 - 1:50 PM
The Already Here Pandemic of Dry Eye
Keynote Presenter:
James S Wolffsohn, BSc, MBA, PhD, FAAO, Professor of Optometry - Aston University
1:50 - 2:25 PM
Today's Therapies are Not Sufficient - a Marketplace Ripe for Innovation
Panelists:
Laura Downie, OD, PhD, Professor - University of Melbourne
David G Evans, OD, Clinical Research Investigator, Optometric Physician - Total Eye Care P.A Memphis
Victor Perez, MD, Professor of Ophthalmology, University of Miami Miller School of Medicine/ Director, Cornea Research Program - Bascom Palmer Eye Institute
Clark L. Springs, MD - Wilmington Eye
James S Wolffsohn, BSc, MBA, PhD, FAAO, Professor of Optometry - Aston University
Moderated By:
Laura Periman, MD, Founder and Director of Dry Eye Services and Clinical Research - Periman Eye Institute
2:25 - 2:55 PM
NETWORKING BREAK
2:55 - 3:50 PM
Potential untapped MOAs & Novel Therapies
Stuart Therapeutics | Eric Schlumpf, President & CEO
Azura Ophthalmics Limited | Charles Bosworth, PhD, Chief Medical Officer
Okyo Pharma | Gary S. Jacob, PhD, CEO & Director
Tear Solutions | Anil C. Asrani, President & CEO
Oculis | Riad Sherif, MD, CEO
Aramis Biosciences | David S. Tierney, MD, CEO
Glia | Wei-Wei Change, PhD, President & Co-Founder
Moderated By:
George Ousler, Senior Vice President, Anterior Segment - Ora
3:50 - 4:55 PM
Optimizing Speed to Market - Clinical Pathway Acceleration
Presenters:
Marc Gleeson, CEO - Azura Ophthalmics Limited
George Ousler, Senior Vice President, Anterior Segment - Ora
David G Evans, OD, Clinical Research Investigator, Optometric Physician - Total Eye Care P.A Memphis
Gustavo de Moraes, MD, PhD, MPH, Chief Medical Officer - Ora / Associate Professor of Clinical Ophthalmology - Columbia University Irving Medical Center
Victor Perez, MD, Professor of Ophthalmology, University of Miami Miller School of Medicine/ Director, Cornea Research Program - Bascom Palmer Eye Institute
Laura Downie, OD, PhD - University of Melbourne
Sonja Krösser, PhD, VP Medical Science & Regulatory Affairs - Novaliq
Gustavo de Moraes, MD, PhD, MPH, Chief Medical Officer - Ora / Associate Professor of Clinical Ophthalmology - Columbia University Irving Medical Center
4:55 - 5:25 PM
The Value for Investment in New Therapies
Panelists:
Todd Brady, MD, PhD, President & CEO - Aldeyra
Doug Faunce, PhD, Executive Director, Head of Search and Evaluation for Eye Care - AbbVie Ventures
Céline Olmiere, PhD, Head - Théa Open Innovation
Mike Rosco, MD, Regional Medical Director - Harrow
Moderated By:
Stewart Sylvester, Chief Sales Officer - Ora
5:25 - 5:45 PM
Closing Remarks
5:45 - 6:45 PM
NETWORKING RECEPTION